1-5 of 5
Peter Kempler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097

Dan Ziegler, MD, Solomon Tesfaye, MD, Peter Kempler, MD
Journal: Diabetes Care
Diabetes Care 2012;35(11):e79
https://doi.org/10.2337/dc12-0817
Published: 13 October 2012
View article titled, Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
Open the PDF for Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 in another window
Journal Articles

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

Solomon Tesfaye, MD, FRCP, Andrew J.M. Boulton, MD, Peter J. Dyck, MD, Roy Freeman, MD, Michael Horowitz, MD, PHD, Peter Kempler, MD, PHD, Giuseppe Lauria, MD, Rayaz A. Malik, MD, Vincenza Spallone, MD, PHD, Aaron Vinik, MD, PHD, Luciano Bernardi, MD, Paul Valensi, MD, on behalf of the Toronto Diabetic Neuropathy Expert Group
Journal: Diabetes Care
Diabetes Care 2010;33(10):2285–2293
https://doi.org/10.2337/dc10-1303
Published: 01 October 2010
View article titled, Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open the PDF for Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments in another window
Journal Articles

Risk Factors of Autonomic and Sensory Nerve Dysfunction in Patients With Newly Diagnosed Type 1 Diabetes

Katalin Keresztes, MD, Ildiko Istenes, MD, Zsolt Hermányi, MD, Peter Vargha, MD, PHD, Istvan Barna, MD, PHD, Peter Kempler, MD, PHD, DSC
Journal: Diabetes Care
Diabetes Care 2003;26(7):2213–2214
https://doi.org/10.2337/diacare.26.7.2213
Published: 01 July 2003
View article titled, Risk Factors of Autonomic and Sensory Nerve Dysfunction in Patients With Newly Diagnosed Type 1 Diabetes
Open the PDF for Risk Factors of Autonomic and Sensory Nerve Dysfunction in Patients With Newly Diagnosed Type 1 Diabetes in another window
Journal Articles

Autonomic Neuropathy and Corrected QT Interval Prolongation: There is a relationship

Peter Kempler, MD, PHD, András Váradi, MD, Ferenc Szalay, MD, PHD, Gyula Tamás, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(5):454–456
https://doi.org/10.2337/diacare.17.5.454
Published: 01 May 1994
View article titled, Autonomic Neuropathy and Corrected QT Interval Prolongation: There is a relationship
Open the PDF for Autonomic Neuropathy and Corrected QT Interval Prolongation: There is a relationship in another window
Journal Articles

Autonomic Neuropathy in Newly Diagnosed Diabetes Mellitus

Peter Kempler, MD, PHD, András Váradi, MD, Gyula Tamás, MD, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(5):848–849
https://doi.org/10.2337/diacare.16.5.848
Published: 01 May 1993
View article titled, Autonomic Neuropathy in Newly Diagnosed Diabetes Mellitus
Open the PDF for Autonomic Neuropathy in Newly Diagnosed Diabetes Mellitus in another window